Arcataur Capital Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,484
Closed -$415K 107
2026
Q1
$415K Hold
5,484
0.12% 74
2025
Q4
$409K Sell
5,484
-10
-0.2% -$731 0.12% 76
2025
Q3
$371K Sell
5,494
-178
-3% -$11.8K 0.11% 80
2025
Q2
$370K Buy
5,672
+59
+1% +$3.54K 0.12% 77
2025
Q1
$347K Sell
5,613
-330
-6% -$21.9K 0.12% 79
2024
Q4
$428K Hold
5,943
0.14% 74
2024
Q3
$484K Sell
5,943
-5
-0.1% -$400 0.16% 66
2024
Q2
$442K Sell
5,948
-40
-0.7% -$3K 0.16% 69
2024
Q1
$467K Hold
5,988
0.17% 62
2023
Q4
$428K Buy
5,988
+395
+7% +$27.5K 0.16% 64
2023
Q3
$388K Hold
5,593
0.16% 62
2023
Q2
$453K Buy
+5,593
New +$457K 0.19% 53

Other funds holding HOLX

Arcataur Capital Management's HOLX Position: Q2 2026 in Review

Arcataur Capital Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 5,484 shares — an estimated $415K sold.

Arcataur Capital Management first reported a position in HOLX in Q2 2023 and held it in 12 quarters. The position peaked at $484K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Arcataur Capital Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Arcataur Capital Management sold 5,484 Hologic shares in Q2 2026, an estimated $415K.
  • Arcataur Capital Management first reported a position in Hologic in Q2 2023 and held it in 12 quarters.
  • Arcataur Capital Management's Hologic position peaked at $484K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.